ニュース
- Philip R. Krause, M.D., Former FDA Deputy Chief for Vaccines, Joins Mesoblast Board
24.03.2022 / 01:40 - GlobeNewswire
-
- Emergent BioSolutions Provides Corporate Governance Update
23.03.2022 / 21:05 - GlobeNewswire
-
- PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
23.03.2022 / 14:30 - pressetext
-
- Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
23.03.2022 / 13:00 - GlobeNewswire
-
- China Xiangtai Food Co., Ltd. Announces Appointment of Dr. Xiaping Cao to Its Board of Directors
22.03.2022 / 21:30 - GlobeNewswire
-
- Voyager Therapeutics Appoints Alfred W. Sandrock, Jr., M.D., Ph.D., as Chief Executive Officer
22.03.2022 / 12:00 - GlobeNewswire
-
- SeqLL Announces Formation of Scientific Advisory Board
21.03.2022 / 21:15 - GlobeNewswire
-
- Absci Appoints Dr. Andreas Busch to Board of Directors
21.03.2022 / 21:05 - GlobeNewswire
-
- Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer
21.03.2022 / 21:01 - GlobeNewswire
-
- Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board
21.03.2022 / 14:37 - GlobeNewswire